Characteristics of patients with transudative efusion followed in an university hospital

Year 2022, Volume: 5 Issue: 5, 1339 - 1344, 25.09.2022

Zeynep Erayman Özen , M. Şule Akçay , Ali Harman , Özgür Özen

https://doi.org/10.32322/jhsm.1132351

Abstract

Aim: To determine the etiological causes, radiological and laboratory features of transudative pleural effusions and to observe the clinical course after therapeutic thoracentesis.
Material and Method: The files of patients with transudative effusion who underwent therapeutic thoracentesis by the Interventional Radiology Department between 01.01.2012 and 30.11.2012 were retrospectively reviewed. Pleural effusion (PE) anatomical features were evaluated with Postero anterior (PA) chest X-ray and Thorax Ultrasonography (USG). Demographic and clinical features, pleural effusion analysis results, presence and rates of complications were analyzed.
Results: As a result of pleural fluid analysis, our study group consisted of 60 transudative pleural effusion cases, 36 (60%) women. The mean age was 71.23±2.36 years. Patients using diuretic therapy in cases with pleural effusion were statistically significantly higher than patients who did not (p<0.05). The most common etiologic causes were Congestive heart failure (CHF) and the accompanying disease hypertension (HT). Fifty (83.3%) of the pleural effusions were unilateral and 39 (65%) of them were right-sided (p<0.05). Diagnostic and therapeutic thoracentesis of our cases was performed by the radiologist under the guidance of thorax USG, and pneumothorax was observed in only one case (1.7%). In our 2-month clinical follow-up, the presence of recurrent pleural effusion was not detected in any of the cases.
Conclusion: In cases with persistent transudative pleural effusion, therapeutic thoracentesis can be considered in cases where fluid resorption is not at the desired level despite effective treatment.

Keywords

Pleural effusion, thorax USG, thoracentesis, transuda

References

• Sahn SA, Heffner JE. Pleural fluid analysis. In: Light RW, Lee YCG, eds. Textbook of pleural diseases. 2nd ed. London: Arnold Press, 2008; 209: e26.
• Fraser RS, Müller NL, Colman N, Pare PD. Fraser and Pare’s Diagnosis of the Diseases of the Chest. 4th ed. Philadelphia; Saunders Compan, 1999: 2739‐68.
• Light R.W. Pleural Diseases. 5th Edition, New York: Lippincott Williams and Wilkins; 2007:2-6.
• Maskell NA, Butland RJ. Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS Guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003; 58: 8-17.
• Light KW. Physiology of pleural space Light KW Pleural Diseas. 5th.Ed.Philadelphia Lippincott Williams&Wilkins 2007: 7-16.
• Çelikoğlu S. Solunum sistemi ve hastalıkları tanı ve tedavi ilkeleri İstanbul 1995; 81-104
• Muruganandan S, Azzopardi M, Thomas R. et al. The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion. Eur Respir J 2020; 55.
• Shojaee S, Khalid M, Kallingal G, Kang L, Rahman N. Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax effusions: a case-control study. Respiration, 2018; 96: 330-7.
• Light RW, Mac Gregor MI, Luchsinger PC et al, Pleural effusıons the diagnostıc seperation of transudates and exudates. Ann Intern Med 1972; 77: 507-13.
• Ünlü M, Şahin Ü, Akkaya A, Doğan A. Plevral efüzyonların etyolojisinin araştırılması. Solunum Hastalıkları 2001; 12: 212-5.
• Turkish Statistical Institute, http://www.tuik.gov.tr , May 2022
• Hacıevliyagil SS, Mutlu LC, Gülbaş G, Yetkin Ö, Günen H. Göğüs hastalıkları servisine yatan hastaların hastane yatış maliyetlerinin karşılaştırılması.Toraks Derg 2006; 7: 11-16.
• Bulut S, Çelik D, Ertürk H, et al. A comparison of idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonia in terms of anterior mediastinal fat properties. J Health Sci Med 2021; 5: 262-68.
• Light RW. Pleural effusions. Med Clin North Am 2011; 95: 1055-70.
• Broaddus VC, Light, RW: Pleural effusions. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA (eds). Murray & Nadel’s Textbook of Respiratory Medicine, 4th ed., Philadelphia: Elsevier Saunders, 2005; 1913-60.
• Romero-Candeira S, Fernández C, Martı́n C, Sánchez-Paya J, Hernández L. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. The American journal of medicine 2001; 110, 681-86.
• Jany B, Welte T. Pleural effusion in adults—etiology, diagnosis, and treatment. Deutsches Ärzteblatt International 2019; 116: 377.
• Kinasewitz GT. Transudative effusion. Eur Respir J 1997; 10: 714-8.
• Light RW. Pleural effusion. N Eng J Med 2002; 346: 1971-7.
• O’Moore PV, Mueller PR, Simeone JF, et al. Sonographic guidance in diagnostic and therapeutic interventions in the pleural space. AJR Am J Roentgenol 1987; 149: 1-5.
• Barnes TW, Morgenthaler TI, Olson EJ, Hesley GK, Decker PA, Ryu JH. Sonographically guided thoracentesis and rate of pneumothorax. J Clin Ultrasound 2005; 33: 442-6.
• Grogan DR, Irwin RS, Channick R, et al. Complications associated with thoracentesis: A prospective randomized study comparing three different methods. Arch Intern Med 1990; 150: 873-77.
• Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ; BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: 32-40.
• Kıral N, Fidan A, Sarac G, Torun E, Tokmak M, Çağlayan B. Plevral efuzyonlarda sıvı miktarı ile etyolojinin ilişkisi. Solunum 2008; 10: 97-101.
• Gonlugur TE, Gonlugur U. Transudates in malignancy: Still a role for pleural fluid. Ann Acad Med Singapore 2008; 37: 760-3.